Barclays PLC Sutro Biopharma, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Barclays PLC holds 158,814 shares of STRO stock, worth $271,571. This represents 0.0% of its overall portfolio holdings.

Number of Shares

158,814

Previous 273,019 41.83%

Holding current value

$271,571

Previous $944,000 68.96%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$1.82 - $4.4 $207,853 - $502,502	-114,205 Reduced 41.83%	158,814 $293,000
Q3 2024 Nov 15, 2024	BUY	$2.88 - $5.01 $624,260 - $1.09 Million	216,757 Added 385.26%	273,019 $944,000
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.33 $68,549 - $125,127	-23,476 Reduced 29.44%	56,262 $164,000
Q1 2024 May 15, 2024	SELL	$3.27 - $5.65 $171,089 - $295,613	-52,321 Reduced 39.62%	79,738 $450,000
Q4 2023 Feb 15, 2024	BUY	$2.07 - $4.54 $143,823 - $315,439	69,480 Added 111.03%	132,059 $566,000
Q3 2023 Nov 07, 2023	BUY	$3.29 - $4.9 $59,525 - $88,655	18,093 Added 40.67%	62,579 $217,000
Q2 2023 Aug 03, 2023	SELL	$4.25 - $5.88 $325,796 - $450,749	-76,658 Reduced 63.28%	44,486 $207,000
Q1 2023 May 04, 2023	BUY	$4.48 - $8.45 $175,817 - $331,620	39,245 Added 47.92%	121,144 $559,000
Q4 2022 Feb 13, 2023	BUY	$5.41 - $8.08 $332,552 - $496,677	61,470 Added 300.9%	81,899 $661,000
Q3 2022 Nov 03, 2022	SELL	$5.17 - $7.11 $17,624 - $24,237	-3,409 Reduced 14.3%	20,429 $114,000
Q2 2022 Aug 12, 2022	SELL	$3.41 - $8.95 $101,457 - $266,289	-29,753 Reduced 55.52%	23,838 $125,000
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $2.34 Million - $4.61 Million	-300,796 Reduced 84.88%	53,591 $441,000
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $338,622 - $559,143	23,763 Added 7.19%	354,387 $5.27 Million
Q3 2021 Nov 09, 2021	BUY	$16.88 - $22.38 $1.55 Million - $2.05 Million	91,630 Added 38.34%	330,624 $6.25 Million
Q2 2021 Aug 13, 2021	SELL	$18.03 - $23.82 $380,955 - $503,292	-21,129 Reduced 8.12%	238,994 $4.44 Million
Q1 2021 May 13, 2021	BUY	$20.29 - $27.54 $608,781 - $826,310	30,004 Added 13.04%	260,123 $5.92 Million
Q4 2020 Feb 11, 2021	SELL	$10.16 - $23.98 $91,500 - $215,963	-9,006 Reduced 3.77%	230,119 $5 Million
Q3 2020 Nov 12, 2020	BUY	$7.44 - $13.15 $13,139 - $23,222	1,766 Added 0.74%	239,125 $2.4 Million
Q2 2020 Aug 12, 2020	BUY	$7.24 - $11.05 $53,706 - $81,968	7,418 Added 3.23%	237,359 $1.84 Million
Q1 2020 May 13, 2020	BUY	$6.19 - $12.16 $1.31 Million - $2.57 Million	211,642 Added 1156.58%	229,941 $2.35 Million
Q4 2019 Feb 10, 2020	BUY	$8.15 - $11.39 $45,371 - $63,408	5,567 Added 43.72%	18,299 $202,000
Q3 2019 Nov 14, 2019	BUY	$7.91 - $11.76 $23,777 - $35,350	3,006 Added 30.91%	12,732 $116,000
Q2 2019 Aug 14, 2019	BUY	$9.69 - $12.23 $76,744 - $96,861	7,920 Added 438.54%	9,726 $111,000
Q1 2019 May 15, 2019	BUY	$8.8 - $11.87 $7,101 - $9,579	807 Added 80.78%	1,806 $21,000
Q4 2018 Feb 14, 2019	BUY	$8.69 - $14.85 $8,681 - $14,835	999 New	999 $9,000

Others Institutions Holding STRO

# of Institutions

128

Shares Held

59.9M

Call Options Held

203K

Put Options Held

33.6K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $89.2M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account